$47.90
2.52% yesterday
Nasdaq, Dec 26, 08:46 pm CET
ISIN
US8342032005
Symbol
SLNO

Soleno Therapeutics Inc Stock price

$49.14
+3.23 7.04% 1M
-35.03 41.62% 6M
+4.19 9.32% YTD
+4.37 9.76% 1Y
+47.65 3,197.99% 3Y
+20.64 72.42% 5Y
-112.11 69.53% 10Y
-241.86 83.11% 20Y
Nasdaq, Closing price Wed, Dec 24 2025
+0.30 0.61%
ISIN
US8342032005
Symbol
SLNO
Industry

Key metrics

Basic
Market capitalization
$2.6b
Enterprise Value
$2.2b
Net debt
positive
Cash
$498.9m
Shares outstanding
53.7m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
26.7 | 14.3
EV/Sales
22.2 | 11.9
EV/FCF
negative
P/B
5.3
Financial Health
Equity Ratio
74.1%
Return on Equity
-71.7%
ROCE
-15.8%
ROIC
-
Debt/Equity
0.1
Financials (TTM | estimate)
Revenue
$98.7m | $184.0m
EBITDA
$-87.3m | $10.8m
EBIT
$-89.3m | $-19.2m
Net Income
$-78.5m | $-3.7m
Free Cash Flow
$-25.9m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
37.7% | 105.8%
EBIT
37.2% | 89.8%
Net Income
40.1% | 97.9%
Free Cash Flow
49.8%
Margin (TTM | estimate)
Gross
98.1%
EBITDA
-88.4% | 5.9%
EBIT
-90.5%
Net
-79.5% | -2.0%
Free Cash Flow
-26.3%
More
EPS
$-1.4
FCF per Share
$-0.5
Short interest
19.6%
Employees
92
Rev per Employee
$0.0
Show more

Is Soleno Therapeutics Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,079 stocks worldwide.

Soleno Therapeutics Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

19 Analysts have issued a Soleno Therapeutics Inc forecast:

18x Buy
95%
1x Hold
5%

Analyst Opinions

19 Analysts have issued a Soleno Therapeutics Inc forecast:

Buy
95%
Hold
5%

Financial data from Soleno Therapeutics Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
99 99
-
100%
- Direct Costs 1.84 1.84
-
2%
97 97
-
98%
- Selling and Administrative Expenses 129 129
77% 77%
130%
- Research and Development Expense 53 53
20% 20%
53%
-87 -87
38% 38%
-88%
- Depreciation and Amortization 2.01 2.01
2% 2%
2%
EBIT (Operating Income) EBIT -89 -89
37% 37%
-90%
Net Profit -78 -78
40% 40%
-79%

In millions USD.

Don't miss a Thing! We will send you all news about Soleno Therapeutics Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Soleno Therapeutics Inc Stock News

Neutral
PRNewsWire
10 days ago
SAN DIEGO , Dec. 15, 2025 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, PLLP is investigating whether Soleno Therapeutics, Inc. (NASDAQ: SLNO) or certain of its officers and directors violated federal securities laws by making false or misleading statements and/or failing to disclose material information to investors. The investigation also examines whether Soleno's public communi...
Neutral
PRNewsWire
22 days ago
SAN DIEGO , Dec. 4, 2025 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, PLLP is investigating whether Soleno Therapeutics, Inc. (NASDAQ: SLNO) or certain of its officers and directors violated federal securities laws by making false or misleading statements and/or failing to disclose material information to investors. The investigation also examines whether Soleno's public communic...
Positive
The Motley Fool
23 days ago
Connecticut-based fund Braidwell bought nearly 1.3 million shares in Soleno Therapeutics during the third quarter. As a result, the net position change from quarter to quarter was about $86.7 million.
More Soleno Therapeutics Inc News

Company Profile

Soleno Therapeutics, Inc. engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. The company focuses on the treatment of metabolic and neurobehavioral disorder. It offers its lead candidate, Diazoxide Choline Controlled-Release (DCCR), an oral tablet for the treatment of Prader-Willi Syndrome (PWS). The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.

Head office United States
CEO Anish Bhatnagar
Employees 92
Founded 1999
Website soleno.life

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today